PharmaVentures Appoints Paul Phull as Senior Director

Aug 31, 2010, 01:59 ET from PharmaVentures

OXFORD, England, August 31, 2010 /PRNewswire/ --

- New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

PharmaVentures Ltd (http://www.pharmaventures.com) ("PharmaVentures") today announced that Paul Phull has joined the company as Senior Director. With more than 24 years of senior level commercial, business/corporate development and general management experience in the pharmaceutical, biotechnology and medical device industries, Paul will be responsible for developing PharmaVentures' Corporate Advisory business.

Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialty pharmaceutical company, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries. He was also responsible for corporate development and worked on the acquisition and integration of European sales and marketing companies in France, Spain and Italy into the Sinclair group. Paul has significant deal making and corporate transaction experience with a broad range and size of companies in Europe, USA, Japan, India and Asia in a number of therapeutic areas.

"I am very pleased to welcome Paul to PharmaVentures," said Dr Fintan Walton, Chief Executive Officer. "His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings."

About PharmaVentures

PharmaVentures Limited (http://www.pharmaventures.com) is based in Oxford, England and is a leading international corporate advisory firm supporting its clients' growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and government bodies. It also produces the highly popular PharmaDeals(R) range of intelligence products including analysis tools and reports. In 2006 it launched the world's first dedicated online pharmaceutical television channel PharmaTelevision(R) ( http://www.pharmatelevision.com)

    Doug Cookson
    Commercial Director,
    PharmaVentures
    T: +44(0)1865-332731
    E: doug.cookson@pharmaventures.com


SOURCE PharmaVentures